Docket

39150

Pfizer Canada ULC v. Pharmascience Inc.

(Federal) (Civil) (By Leave)

Judgments on applications for leave to appeal are rendered by the Court, but are not necessarily unanimous.

Proceedings
Date Proceeding Filed By
(if applicable)
2021-03-05 Close file on Leave
2020-12-11 Copy of formal judgment sent to Registrar of the Court of Appeal and all parties
2020-12-11 Judgment on leave sent to the parties
2020-12-10 Judgment of the Court on the application for leave to appeal, The application for leave to appeal from the judgment of the Federal Court of Appeal, Number A-405-19, 2020 FCA 55, dated February 25, 2020, is dismissed with costs.
Dismissed, with costs
2020-11-02 All materials on application for leave submitted to the Judges, for consideration by the Court
2020-11-02 Certificate (on limitations to public access), (Letter Form), 23B - Reply Pfizer Canada ULC
2020-10-26 Applicant's reply to respondent's argument, (Book Form), Missing: Form 23B (rec' 11/02/20), Completed on: 2020-11-03 Pfizer Canada ULC
2020-10-14 Supplemental document, (Letter Form), Protective Order Pharmascience Inc.
2020-10-14 Certificate (on limitations to public access), (Letter Form), 23B, (Printed version filed on 2020-10-16) Pharmascience Inc.
2020-10-14 Certificate (on limitations to public access), (Letter Form), 23A, (Printed version filed on 2020-10-16) Pharmascience Inc.
2020-10-14 Notice of name, (Letter Form), (Printed version filed on 2020-10-16) Pharmascience Inc.
2020-10-14 Respondent's response on the application for leave to appeal, (Book Form), Completed on: 2020-10-14, (Printed version filed on 2020-10-16) Pharmascience Inc.
2020-05-12 Letter acknowledging receipt of a complete application for leave to appeal, FILE OPENED 2020/05/12
2020-04-27 Certificate (on limitations to public access), (Letter Form), 23B Pfizer Canada ULC
2020-04-27 Notice of name, (Letter Form) Pfizer Canada ULC
2020-04-27 Certificate (on limitations to public access), (Letter Form), 23A Pfizer Canada ULC
2020-04-27 Application for leave to appeal, (Book Form), Completed on: 2020-04-27 Pfizer Canada ULC